Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study-Reference-Cited by-同舟云学术

Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

Published:2010-03-22 Issue:8 Volume:12 Page:700-708
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Iwamoto Y.,Kashiwagi A.,Yamada N.,Terao S.,Mimori N.,Suzuki M.,Tachibana H.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2010.01222.x/fullpdf

Reference28 articles.

1. 2007

2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004

3. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report.;Koro;Diabetes Care,2004

4. Oral antihyperglycemic therapy for type 2 diabetes mellitus;Cheng;CMAJ,2005

5. The importance of tight glycemic control;Gerich;Am J Med,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Teneligliptin in comparison with Voglibose as an add on therapy in reducing microvascular complications in type II Diabetes Mellitus patients – A Prospective randomized control trial;Research Journal of Pharmacy and Technology;2023-12-29

2. Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis;Advances in Therapy;2021-11-30

3. Hypoglycemia possibly caused by CYP2C9-mediated drug interaction in combination with bucolome: a case report;Journal of Pharmaceutical Health Care and Sciences;2021-11-03

4. The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE—A multicenter randomized controlled trial;BMC Cardiovascular Disorders;2021-02-15

5. Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis;PLOS ONE;2020-07-24